Free Trial

Danaher (DHR) Stock Forecast & Price Target

Danaher logo
$236.53 -1.15 (-0.48%)
(As of 11/26/2024 ET)

Danaher - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
5
Buy
14

Based on 19 Wall Street analysts who have issued ratings for Danaher in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 5 have given a hold rating, and 14 have given a buy rating for DHR.

Consensus Price Target

$287.16
21.40% Upside
According to the 19 analysts' twelve-month price targets for Danaher, the average price target is $287.16. The highest price target for DHR is $315.00, while the lowest price target for DHR is $250.00. The average price target represents a forecasted upside of 21.40% from the current price of $236.53.
Get the Latest News and Ratings for DHR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Danaher and its competitors.

Sign Up

DHR Analyst Ratings Over Time

TypeCurrent Forecast
11/27/23 to 11/26/24
1 Month Ago
10/28/23 to 10/27/24
3 Months Ago
8/29/23 to 8/28/24
1 Year Ago
11/27/22 to 11/27/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
14 Buy rating(s)
13 Buy rating(s)
11 Buy rating(s)
14 Buy rating(s)
Hold
5 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$287.16$287.28$278.94$257.73
Forecasted Upside21.40% Upside17.07% Upside4.84% Upside17.15% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

DHR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DHR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Danaher Stock vs. The Competition

TypeDanaherMulti-Sector Conglomerates CompaniesS&P 500
Consensus Rating Score
2.74
2.74
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside21.38% Upside17.37% Upside6.71% Upside
News Sentiment Rating
Positive News

See Recent DHR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/31/2024Wolfe Research
3 of 5 stars
D. Schenkel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$285.00+17.61%
10/23/2024TD Cowen
4 of 5 stars
 Boost TargetBuy ➝ Buy$310.00 ➝ $315.00+23.29%
10/23/2024Royal Bank of Canada
4 of 5 stars
 Lower TargetOutperform ➝ Outperform$333.00 ➝ $311.00+21.73%
10/23/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Johnson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$315.00 ➝ $315.00+23.29%
10/23/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$309.00 ➝ $305.00+19.66%
10/23/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$250.00 ➝ $265.00+3.97%
❗[Investor Alert] Under-the-Radar Tech (Ad)

While most investors are caught up in cryptocurrencies, AI stocks, or Jim Cramer's latest "hot pick…" One company that most have never heard of is making waves in the global music market…TuneGO

Click here for all the details about today's open round of investing.
10/23/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$310.00 ➝ $300.00+16.48%
10/23/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$290.00 ➝ $310.00+19.45%
10/23/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$285.00 ➝ $275.00+5.25%
10/23/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$278.00 ➝ $277.00+6.02%
10/1/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
V. Kumar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$275.00 ➝ $278.00+1.41%
8/27/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Couillard
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$280.00+4.16%
7/24/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$275.00 ➝ $280.00+5.22%
7/24/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$225.00 ➝ $250.00-6.32%
7/24/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$270.00 ➝ $275.00+4.10%
6/3/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$295.00+13.35%
4/24/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$280.00 ➝ $290.00+16.02%
4/17/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$250.00 ➝ $280.00+16.93%
12/20/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$250.00 ➝ $270.00+17.71%
5/1/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$300.00+26.63%
4/27/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$310.00 ➝ $275.00+18.29%
4/26/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Larew
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
4/26/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$300.00 ➝ $270.00+16.38%
1/25/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$340.00 ➝ $320.00+17.83%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 06:32 PM ET.


Should I Buy Danaher Stock? DHR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, November 22, 2024. Please send any questions or comments about these Danaher pros and cons to contact@marketbeat.com.

Danaher
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Danaher Co.:

  • Danaher Co. reported earnings per share (EPS) of $1.71 for the latest quarter, exceeding analysts' expectations of $1.57. This strong performance indicates robust financial health and effective management, which can attract more investors.
  • The company achieved a revenue of $5.80 billion for the quarter, surpassing the consensus estimate of $5.59 billion. This growth reflects Danaher Co.'s ability to expand its market presence and increase sales, which is a positive sign for potential investors.
  • Danaher Co. has a solid return on equity of 10.62%, indicating that the company is effectively using shareholders' equity to generate profits. A higher return on equity is generally viewed favorably by investors.
  • The recent quarterly dividend of $0.27, which translates to an annualized dividend of $1.08 and a yield of 0.47%, provides a steady income stream for investors. The payout ratio of 20.61% suggests that the company retains a significant portion of its earnings for growth while still rewarding shareholders.
  • With a consensus rating of "Moderate Buy" and a price target of $287.16, analysts are optimistic about Danaher Co.'s future performance. This positive outlook can encourage investors to consider the stock as a viable investment option.

Danaher
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Danaher Co. for these reasons:

  • Despite the recent earnings beat, Danaher's EPS has decreased from $2.02 in the same quarter last year. This decline may raise concerns about the company's long-term profitability and growth potential.
  • The stock price has seen fluctuations, and while it is currently performing well, any significant market downturn could negatively impact investor sentiment and stock value.
  • Insider selling activity, such as the recent sale of 952 shares by a senior vice president, may signal a lack of confidence in the company's short-term prospects. Such actions can lead to uncertainty among investors.
  • With a significant number of analysts rating the stock as a hold, there may be limited upside potential in the near term. This cautious stance could deter some investors looking for aggressive growth opportunities.
  • The company's net margin of 16.39% is respectable, but it may not be as high as some competitors in the industry, which could limit Danaher Co.'s competitive edge and attractiveness to investors seeking high-margin companies.

DHR Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Danaher is $287.16, with a high forecast of $315.00 and a low forecast of $250.00.

19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 5 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DHR shares.

According to analysts, Danaher's stock has a predicted upside of 21.40% based on their 12-month stock forecasts.

Over the previous 90 days, Danaher's stock had 1 upgrade by analysts.

Danaher has been rated by research analysts at Barclays, Evercore ISI, KeyCorp, Raymond James, Robert W. Baird, Royal Bank of Canada, Stephens, Stifel Nicolaus, TD Cowen, UBS Group, and Wolfe Research in the past 90 days.

Analysts like Danaher less than other "multi-sector conglomerates" companies. The consensus rating score for Danaher is 2.74 while the average consensus rating score for "multi-sector conglomerates" companies is 2.74. Learn more on how DHR compares to other companies.


This page (NYSE:DHR) was last updated on 11/26/2024 by MarketBeat.com Staff
From Our Partners